Mayo Clinic to Use Siemens' Molecular Dx Tools | GenomeWeb

NEW YORK (GenomeWeb News) – Siemens Healthcare Diagnostics will provide the Mayo Clinic with two of its molecular testing products for use in screening for major diseases, Siemens said today.

Under the five-year agreement, the Mayo Clinic will use Siemens’ Versant and Trugene products to assess human immunodeficiency virus, hepatitis B and hepatitis C viral load, genotyping, and drug resistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.